Fisher & Paykel Healthcare Corporation Limited

PNK:FSPKF

$20.2 USD

-$2.8 (-12.17%)

Volume
300
Average Volume
514
Market Capitalization
$11.84B
P/E Ratio
121.92
Dividend Yield
1.09%
Price Target
$23.65
Year High
$25.71
Year Low
$14.00
Payout Ratio
$1.00
Current Ratio
$1.83

Industry, Sector & symbol

Stock Exchange Other OTC
CEO Mr. Lewis G. Gradon
Industry Medical - Instruments & Supplies
Sector Healthcare
Current Symbol FSPKF
CUSIP None
CIK None
Web https://www.fphcare.com
Phone 64 9 574 0100
Currency USD
Employees 6978
Country NZ

Liquidity

Debt-to-Equity Ratio 0.06
Payout Ratio 1.00
Current Ratio 1.83
Quick Ratio 1.00
Cash Ratio 0.21

Sales & Book Value

Annual Sales $1.76B
Price / Sales 10.34
Cash Flow 0.08
Price / Cash Flow 469.52
Price / Book 12.91

Price Target and Rating

Average Stock Price Forecast $23.65
High Stock Price Forecast $26.00
Low Stock Price Forecast $21.30
Forecast Upside/Downside -14.59%
Consensus Rating Neutral
Rating Score(0-5) 3
Research Coverage 0 Analysts

Profitability

EPS (Most Recent Fiscal Year) $0.23
Trailing P/E Ratio 121.92
PEG Ratio -2.73
P/E Growth -2.73
Net Income $132.6M
Net Margin 8.64%
Pretax Margin 14.19%
Return on Equity 10.90%
Return on Assets 8.16%

Financials Score

AltmanZ Score 16.00
Piotroski Score 6.00
Working Capital 319.9M
Total Assets 2.28B
Ebit 426.4M
Market Cap 11.84B
Total Liabilities 522.6M

Poll Results

About Fisher & Paykel Healthcare Corporation Limited (PNK:FSPKF) Stock

Fisher & Paykel Healthcare Corporation Limited, together with its subsidiaries, designs, manufactures, markets, and sells medical device products and systems worldwide. It also provides its products for use in acute and chronic respiratory care, and surgery, as well as the treatment of obstructive sleep apnea (OSA) in the home and hospital. The company offers Airvo 2, a humidified nasal high flow system; Optiflow, a nasal high flow therapy; and F&P 850 System, a noninvasive and invasive ventilation system. In addition, it provides infant respiratory products, such as resuscitation, continuous positive airway pressure (CPAP) therapy, and nasal high flow therapy products. Further, the company offers hospital products, including humidification products, breathing circuits, chambers, masks, na ... sal cannulas, surgical, accessories, and interfaces; and homecare products that include masks, CPAP devices, software and data management products, humidifiers, and accessories. Fisher & Paykel Healthcare Corporation Limited was founded in 1934 and is headquartered in Auckland, New Zealand.

Fisher & Paykel Healthcare Corporation Limited (FSPKF) Q2 2025 Earnings Call Transcript

2024-11-27 19:40:28

Fisher & Paykel Healthcare Corporation Limited (OTCPK:FSPKF) Q2 2025 Earnings Call Transcript November 27, 2024 4:00 PM ET Company Participants Marcus Driller - VP, Corporate Lewis Gradon - MD and CEO Lyndal York - CFO Conference Call Participants Lyanne Harrison - BofA Craig Wong-Pan - RBC Daniel Hurren - MST Marquee Adrian Allbon - Jarden Vanessa Thomson - Jefferies Matt Montgomerie - Forsyth Barr Mathieu Chevrier - Citi Andrew Paine - CLSA Saul Hadassin - Barrenjoey Marcus Curley - UBS David Low - JPMorgan Rob Morrison - Craigs Operator Welcome to Fisher & Paykel Healthcare's Results Conference Call. My name is Taryn and I'll be your operator for today's call.

Fisher & Paykel Healthcare Corporation Limited (FSPKF) Q4 2024 Earnings Call Transcript

2024-05-29 00:17:05

Fisher & Paykel Healthcare Corporation Limited (OTCPK:FSPKF) Q4 2024 Earnings Conference Call May 28, 2024 6:00 PM ET Company Participants Marcus Driller - VP, Corporate Lewis Gradon - Managing Director & CEO Lyndal York - CFO Justin Callahan - VP Sales & Marketing Andrew Somervell - VP, Products & Technology Conference Call Participants Lyanne Harrison - Bank of America Dan Hurren - MST Marquee Gretel Janu - E&P Adrian Allbon - Jarden Vanessa Thomson - Jefferies Mathieu Chevrier - Citi Stephen Ridgewell - Craigs David Low - JPMorgan Matt Montgomerie - Forsyth Barr Saul Hadassin - Barrenjoey Markets Andrew Paine - CLSA Craig Wong-Pan - RBC David Bailey - Macquarie Christian Bell - Jarden Operator Welcome to Fisher & Paykel Healthcare's results conference call. My name is Cynthia, and I'll be your operator for today's call.

Fisher & Paykel Healthcare Corporation Limited (FSPKF) Q2 2024 Earnings Call Transcript

2023-11-28 17:45:06

Fisher & Paykel Healthcare Corporation Limited (OTCPK:FSPKF) Q2 2024 Earnings Conference Call November 28, 2023 4:00 PM ET Company Participants Marcus Driller - Vice President of Corporate Lewis Gradon - Managing Director & Chief Executive Officer Lyndal York - Chief Financial Officer Paul Shearer - Senior Vice President of Sales & Marketing Conference Call Participants Gretel Janu - E&P Chris Cooper - Goldman Sachs Dan Hurren - MST Marquee David Low - JPMorgan Craig Wong-Pan - RBC Vanessa Thomson - Jefferies Saul Hadassin - Barrenjoey Markets Adrian Allbon - Jarden Matt Montgomerie - Forsyth Barr Sean Laaman - Morgan Stanley Marcus Curley - UBS Christian Bell - Jarden Mathieu Chevrier - Citi David Bailey - Macquarie Operator Please standby. Welcome to Fisher & Paykel Healthcare's Results Conference Call.

Frequently Asked Questions

What is the current Fisher & Paykel Healthcare Corporation Limited (FSPKF) stock price?

Fisher & Paykel Healthcare Corporation Limited(PNK:FSPKF) stock price is $20.2 in the last trading session. During the trading session, FSPKF stock reached the peak price of $25.71 while $12.55 was the lowest point it dropped to. The percentage change in FSPKF stock occurred in the recent session was --12.17% while the dollar amount for the price change in FSPKF stock was -$-2.8.

FSPKF's industry and sector of operation?

The PNK listed FSPKF is part of Medical - Instruments & Supplies industry that operates in the broader Healthcare sector.

Who are the executives of FSPKF?

Mr. Lewis G. Gradon | MD, Chief Executive Officer & Executive Director
Mr. Andy Niccol | Chief Operating Officer & GM of Respiratory Humidification
Mr. Hayden Brown | Head of Capital Markets & Investor Relations
Mr. Justin Callahan | Vice President of Sales & Marketing and President of North America & Europe
Raelene Leonard | Company Secretary & General Counsel

How many employees does FSPKF have?

Number of FSPKF employees currently stands at 6978. FSPKF operates from 15 Maurice Paykel Place, Auckland, None 2013, NZ.

Link for FSPKF official website?

Official Website of FSPKF is: https://www.fphcare.com

How do I contact FSPKF?

FSPKF could be contacted at phone #64 9 574 0100 and can also be accessed through its website. FSPKF operates from 15 Maurice Paykel Place, Auckland, None 2013, NZ.

How many shares of FSPKF are traded daily?

The average number of FSPKF shares traded daily for last 3 months was 514.

What is the market cap of FSPKF currently?

The market value of FSPKF currently stands at $11.84B with its latest stock price at $20.2